SCHEMBL3640935

SCHEMBL3640935

CCC(C#N)c1cccc(C(=O)OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.47
CYP4F2 P78329 2/20 0.46
CYP4A11 Q02928 2/20 0.46
KMT2A Q03164 3/20 0.44
SLC7A5 Q01650 1/20 0.44
CASR P41180 1/20 0.43
TSHR P16473 1/20 0.42
RAB9A P51151 2/20 0.41
POLB P06746 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.41
TP53 P04637 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 2/20 0.40
CYP3A4 P08684 2/20 0.40
MAPK1 P28482 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2337192 0.85 ANPEP (0.51) KMT2ASMN1; SMN2ALDH1A1CYP3A4MAPK1
SCHEMBL2336820 0.82 KMT2A (0.40) KMT2ATSHRPOLBSMN1; SMN2ALDH1A1
SCHEMBL20504196 0.82 MAPT (0.46) LOXL2KMT2ATSHRALDH1A1CYP3A4
SCHEMBL935891 0.82 LOXL2 (0.47) LOXL2CYP4F2CYP4A11KMT2ASLC7A5
SCHEMBL2522006 0.81 LOXL2 (0.46) LOXL2CYP4F2CYP4A11KMT2ASLC7A5
SCHEMBL17380991 0.81 LOXL2 (0.44) LOXL2CYP4F2CYP4A11SLC7A5CASR
SCHEMBL11457916 0.81 HPGD (0.36) LOXL2KMT2ACASRTSHRPOLB
SCHEMBL20032090 0.80 LOXL2 (0.53) LOXL2CYP4F2CYP4A11KMT2ASLC7A5
SCHEMBL10606809 0.79 LOXL2 (0.51) LOXL2CYP4F2CYP4A11KMT2ASLC7A5
SCHEMBL28346938 0.79 HDAC4 (0.51) LOXL2CYP4F2CYP4A11SLC7A5CASR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2162445-A1 HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2010-03-17 EP disclosed
EP-2049541-A2 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-04-22 EP disclosed
WO-2008150015-A1 HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-11 WO disclosed
WO-2008016192-A2 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-02-07 WO disclosed
EP-0525506-B2 A process for the alpha-monoalkylation of arylacetonitriles, arylacetoesters and arylacetic acids TESSENDERLO CHEM NV (BE) 1999-03-17 EP disclosed
US-5278333-A Heat treatment TESSENDERLO CHEMIE N.V. (BE) 1994-01-11 US disclosed
EP-0525506-A2 A process for the alpha-monoalkylation of arylacetonitriles, arylacetoesters and arylacetic acids TESSENDERLO CHEMIE N.V. (BE) 1993-02-03 EP disclosed